• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Chile Pharmaceuticals and Healthcare Report Q3 2009 - Product Image

Chile Pharmaceuticals and Healthcare Report Q3 2009

  • ID: 1056760
  • July 2009
  • Region: Chile
  • 71 Pages
  • Business Monitor International

Business Monitor International's Chile Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Chile's pharmaceuticals and healthcare industry.

In BMI’s Q309 Business Environment Rankings for the 10 markets of the Americas, Chile receives a slightly lower composite pharmaceutical rating, but remains ranked seventh out of the 10 markets surveyed in the Americas. Downward revisions to economic fundamentals have conspired to lower most countries’ scores, and Chile’s attractiveness will continue to suffer due to limited reimbursement, low retail drugs prices caused by strong competition, and the deficient intellectual property (IP) environment.

In fact, Chile is once again featured on the 2009 Priority Watch List prepared by the Pharmaceutical Research and Manufacturers of America (PhRMA)’s Special 301 Submission. The two key problems in Chile for research-based drugmakers remain data protection and the lack of co-ordination between the patent office and medicines regulator. READ MORE >

Executive Summary

SWOT Analysis
- Chile Pharmaceuticals And Healthcare Industry SWOT
- Chile Political SWOT
- Chile Economic SWOT
- Chile Business Environment SWOT

Pharmaceutical Business Environment Ratings
- Table: Americas – Regional Pharmaceutical Business Environment Ratings for Q309
- Limits Of Potential Returns
- Risks To Realisation Of Returns
- Chile – Market Summary

Regulatory Regime
- Recent Regulatory Developments
- Intellectual Property
- IP Deficiencies
- Recent IP Developments
- Trade Agreements
- Pricing Regime
- Reimbursement Regime

Industry Developments
- Epidemiology
- DALYs Lost To All Diseases And Injuries Per 100,00 Population In Select South American Countries
- Healthcare Sector
- Healthcare Insurance

Pharmaceutical Sector
- Table: Latin American Regulations On Bioequivalence And GMP
- Domestic Industry
- Foreign Industry
- Recent Pharmaceutical Industry Developments
- OTC Medicines
- Pharmaceutical Retail Sector
- Clinical Trials
- Medical Devices

Industry Forecast Scenario
- Overall Market Forecast
- Table: Chile - Drug Market Expenditure Indicators, Historical Data and Forecasts
- Key Growth Factors – Industry
- Table: Chile - Health Expenditure Indicators, Historical Data and Forecasts
- Key Growth Factors – Macroeconomic
- Fiscal Stimulus to Keep Economy Afloat
- Table: Chile - Economic Activity, 2006-2013
- Prescription Market Forecast
- Table: Chile - Prescription Market Indicators, Historical Data and Forecasts (CLPmn unless otherwise stated)
- Patented Market Forecast
- Table: Chile - Patented Drug Market Indicators, Historical Data and Forecasts
- Generics Market Forecast
- Generics Market Forecast
- Table: Chile - Generics Drug Market Indicators, Historical Data and Forecasts
- OTC Market Forecast
- Table: Chile - OTC Market Indicators, Historical Data and Forecasts (CLPmn unless otherwise stated)
- Pharmaceutical Trade Forecast
- Table: Chile - Pharmaceutical Trade Indicators, Historical Data and Forecasts (US$mn)
- Medical Devices Forecasts
- Table: Chile - Medical Device Indicators, Historical Data And Forecasts
- Other Healthcare Data
- Table: Chile – Other Healthcare Indicators, Historical Data and Forecasts
- Key Risks To BMI’s Forecast Scenario

Competitive Landscape
- Company Monitor
- Leading Multinationals
- Pfizer
- Novartis
- Sanofi-Aventis
- Indigenous Companies
- Laboratorios Chile (LabChile)
- Country Snapshot: Chile Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators, 2001-2006
- Table: Consumer Expenditure, 2000-2012 (US$)
- Table: Average Annual Wages, 2000-2012

BMI Forecast Modelling
- How The Publisher Generates their Pharmaceutical Industry Forecasts
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos